Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes

US Patent 10662170 · Granted May 26, 2020

Estimated economic value: $121,919,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Common sense reasoning for deepfake detection2025
Collections of peptides, peptide agents, and methods of use thereof2025
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof2025
Immunoglobulins and uses thereof2024
Lactic acid bacteria and its applications2024
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof2024
Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors2023
Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine t2023
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neu2023
Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y recep2023
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neu2023
Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors2022